Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis

    NEXT STORY
    iBio Selected to Produce ATB Therapeutics’ Bioengineered Antibody-Toxin Fusion Proteins
    PREV STORY
    Micron Medical Hosting Key Opinion Leader Webinar on Protect PNS: A Percutaneous Wireless Micro-Neurostimulation Technology for Overactive Bladder December 9 at 11am EST
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2015 Annual Meeting

    CAMBRIDGE, Mass., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: FIT BIOTECH PROMOTES LIISA LAITINEN TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

    FIT BIOTECH OYCOMPANY RELEASE 4 July 2016 at 10.00 EETFIT BIOTECH PROMOTES LIISA LAITINEN ...

    author_avatar
    NASDAQ Market News

    TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update

    SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...

    author_avatar
    NASDAQ Market News